These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6152289)

  • 1. Transmitter release in botulinum-poisoned muscles.
    Thesleff S
    J Physiol (Paris); 1984; 79(4):192-5. PubMed ID: 6152289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Miniature end-plate potentials in rat skeletal muscle poisoned with botulinum toxin.
    Kim YI; Lømo T; Lupa MT; Thesleff S
    J Physiol; 1984 Nov; 356():587-99. PubMed ID: 6520797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin and 4-aminoquinoline induce a similar abnormal type of spontaneous quantal transmitter release at the rat neuromuscular junction.
    Thesleff S; Molgó J; Lundh H
    Brain Res; 1983 Mar; 264(1):89-97. PubMed ID: 6133583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Action of botulinum A toxin and tetanus toxin on synaptic transmission.
    Dreyer F; Becker C; Bigalke H; Funk J; Penner R; Rosenberg F; Ziegler M
    J Physiol (Paris); 1984; 79(4):252-8. PubMed ID: 6152293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of botulinum toxin on neuromuscular transmission in the rat.
    Cull-Candy SG; Lundh H; Thesleff S
    J Physiol; 1976 Aug; 260(1):177-203. PubMed ID: 184273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presynaptic actions of botulinal neurotoxins at vertebrate neuromuscular junctions.
    Molgo J; Comella JX; Angaut-Petit D; Pecot-Dechavassine M; Tabti N; Faille L; Mallart A; Thesleff S
    J Physiol (Paris); 1990; 84(2):152-66. PubMed ID: 2290130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spontaneous transmitter release in experimental neuromuscular disorders of the rat.
    Thesleff SW
    Muscle Nerve; 1982; 5(9S):S12-6. PubMed ID: 6302487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hexamethonium- and methyllycaconitine-induced changes in acetylcholine release from rat motor nerve terminals.
    Tian L; Prior C; Dempster J; Marshall IG
    Br J Pharmacol; 1997 Nov; 122(6):1025-34. PubMed ID: 9401765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Ca2+ channel blocker neurotoxins on transmitter release and presynaptic currents at the mouse neuromuscular junction.
    Katz E; Protti DA; Ferro PA; Rosato Siri MD; Uchitel OD
    Br J Pharmacol; 1997 Aug; 121(8):1531-40. PubMed ID: 9283685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discrepancies between spontaneous and evoked synaptic potentials at normal, regenerating and botulinum toxin poisoned mammalian neuromuscular junctions.
    Colméus C; Gomez S; Molgó J; Thesleff S
    Proc R Soc Lond B Biol Sci; 1982 Apr; 215(1198):63-74. PubMed ID: 6127697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different effects of types A and B botulinum toxin on transmitter release at the rat neuromuscular junction.
    Sellin LC; Thesleff S; Dasgupta BR
    Acta Physiol Scand; 1983; 119(2):127-33. PubMed ID: 6140815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of synchronization of quantal transmitter release from mammalian motor endings by the use of botulinal toxins type A and D.
    Molgó J; Siegel LS; Tabti N; Thesleff S
    J Physiol; 1989 Apr; 411():195-205. PubMed ID: 2575665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of action of lead on neuromuscular junctions.
    Atchison WD; Narahashi T
    Neurotoxicology; 1984; 5(3):267-82. PubMed ID: 6097847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4-aminoquinoline-induced 'giant' miniature endplate potentials at mammalian neuromuscular junctions.
    Molgó J; Thesleff S
    Proc R Soc Lond B Biol Sci; 1982 Jan; 214(1195):229-44. PubMed ID: 6127680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transmitter release in tetanus and botulinum A toxin-poisoned mammalian motor endplates and its dependence on nerve stimulation and temperature.
    Dreyer F; Schmitt A
    Pflugers Arch; 1983 Nov; 399(3):228-34. PubMed ID: 6140670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aminoglycosides and 3,4-diaminopyridine on neuromuscular block caused by botulinum type A toxin.
    Molgó J; Lemeignan M; Thesleff S
    Muscle Nerve; 1987 Jun; 10(5):464-70. PubMed ID: 3497343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the actions of botulinum neurotoxin type E at the rat neuromuscular junction.
    Molgó J; Dasgupta BR; Thesleff S
    Acta Physiol Scand; 1989 Dec; 137(4):497-501. PubMed ID: 2557728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the mode of action of botulinum toxin type A at the frog neuromuscular junction.
    Molgó J; Thesleff S
    Brain Res; 1984 Apr; 297(2):309-16. PubMed ID: 6326941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre- and post-synaptic actions of botulinum toxin at the rat neuromuscular junction.
    Sellin LC; Thesleff S
    J Physiol; 1981 Aug; 317():487-95. PubMed ID: 6273549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spontaneous output of acetylcholine from rat diaphragm preparations declines after treatment with botulinum toxin.
    Gundersen CB; Jenden DJ
    J Pharmacol Exp Ther; 1983 Feb; 224(2):265-8. PubMed ID: 6822953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.